Stay updated with breaking news from Schuler Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Only a small percentage of older adults who are in the early stages of Alzheimer's disease meet the eligibility criteria to receive new monoclonal antibody treatments, drugs that target amyloid-ß plaques in the brain, an early sign of Alzheimer's disease.
People who have sleep apnea and spend less time in deep sleep may be more likely to have brain biomarkers that have been linked to an increased risk of stroke, Alzheimer's disease and cognitive decline, according to new research published in the May 10, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.
People who have sleep apnea and spend less time in deep sleep may be more likely to have brain biomarkers that have been linked to an increased risk of stroke, Alzheimer’s disease and cognitive decline, according to new research published in the May 10, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that these sleep disturbances cause the changes in the brain, or vice versa. It only shows an association
The College of the Holy Cross in Worcester will expand its financial aid support of low-income students and students with undocumented status by $40 million.
/PRNewswire/ -- A partnership between Union College and the Schuler Education Foundation will invest $42 million to enroll significantly more low-income...